期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Carbonic anhydrase isozymes Ⅺ and Ⅻ in gastric tumors 被引量:4
1
作者 MariLeppilamDi JuhaSaarnio +7 位作者 TuomoJ.Karttunen JyrkiKivelae SilviaPastorekova JaromirPastorek AbdulWaheed Will iamS.Sly SeppoParkkila 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第7期1398-1403,共6页
AIM: To systematically study the expression of carbonic anhydrase (CA) isowmes Ⅸ and Ⅻ in gastric tumors.METHODS: We analyzed a representative series of specimens from non-neoplastic gastric mucosa and from various ... AIM: To systematically study the expression of carbonic anhydrase (CA) isowmes Ⅸ and Ⅻ in gastric tumors.METHODS: We analyzed a representative series of specimens from non-neoplastic gastric mucosa and from various dysplastic and neoplastic gastric lesions for the expression of CA IX and XII. Immunohistochemical staining was performed using isozyme-specific antibodies and biotinstreptavidin complex method.RESULTS: CA IX was highly expressed in the normal gastric mucosa and remained positive in many gastric tumors. In adenomas, CA IX expression significantly decreased towards the high grade dysplasia. However, the expression resumed back to the normal level in well differentiated adenocarcinomas,while it again declined in carcinomas with less differentiation.In comparison, CA Ⅻ showed no or weak immunoreaction in the normal gastric mucosa and was slightly increased in tumors.CONCLUSION: These results demonstrate that CA Ⅸexpression is sustained in several types of gastric tumors.The variations observed in the CA Ⅸ levels support the concept that gastric adenomas and carcinomas are distinct entities and do not represent progressive steps of a single pathway. 展开更多
关键词 胃癌 CA 同工酶 免疫组织化学
下载PDF
Early diagnosis of prostate cancer using free/total prostate specific antigen ratio: a population based screening data
2
作者 LingZhang Guo-YIJi +6 位作者 Xiao-MengLi Wei-HuaWang Hong-WenGao Yu-ZhuoPan Hong-JunWang KuwaharaMasaaki Xue-JianZhao 《Asian Journal of Andrology》 SCIE CAS CSCD 2004年第4期342-342,共1页
Aim: To evaluate the use of free/total prostate specific antigen ratio (fPSA/tPSA ratio) in improving the early diagnosis of prostate cancer. Methods: The fPSA/tPSA ratio in the serum was analyzed in 187 men with tPSA... Aim: To evaluate the use of free/total prostate specific antigen ratio (fPSA/tPSA ratio) in improving the early diagnosis of prostate cancer. Methods: The fPSA/tPSA ratio in the serum was analyzed in 187 men with tPSA ranging between 4.0 and 20.0 μg/L. All of them underwent ultrasound guided sextant prostatic biopsy. The results were calculated by SPSS 10.0 software. Results: (1) When the tPSA was within the ranges of 4.0 - 10.0 and 10.0 -20.0 μg/L, the prostate cancer detection rate was 18.1 % and 22.5 %, respectively; (2) The area under the curve (AUC) was bigger in fPSA/tPSA than in tPSA (P<0.05) in all the men; (3) When the cut off value of fPSA/tPSA ratio was set at 0.25 and the tPSA at 4.0 - 10.0 μg/L and 10.0 - 20.0 μg/L, the diagnostic sensitivity of tPSA was 90.5 % and 87.5 %, respectively. Thus at the tPSA ranges of 4.0 - 10.0 and 10.0 - 20.0 μg/L, 26.7 % and 11.3 % of biopsies could be avoided, respectively. Conclusion: The use of fPSA/tPSA ratio can improve the prostate cancer detection rate and reduce unnecessary biopsies when tPSA is within the range of 4.0 - 20.0 μg/L. 展开更多
关键词 prostate cancer prostate specific antigen free/total PSA ratio
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部